Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Drug Resistance

Free Subscription 23.02.2026 5 Antimicrob Agents Chemother 2 Clin Infect Dis 2 Emerg Infect Dis 1 Infect Control Hosp Epidemiol 3 Int J Antimicrob Agents 3 J Antimicrob Chemother 2 J Clin Microbiol 1 J Infect Chemother 3 J Infect Dis 1 J Med Microbiol 1 J Virol 2 PLoS One 2 Sex Transm Infect 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. DELLIS C, Laros G, Georgiou K, Zhang L, et al
   Iotadentification of SQ109 analogs with enhanced antimicrobial activity against methicillin-resistant Staphylococcus aureus.
   Antimicrob Agents Chemother. 2026 Feb 18:e0154525. doi: 10.1128/aac.01545.
   PubMed         Abstract available
   
   
2. LI P, Xiao Y, Luo R, Zhang J, et al
   Comparative genomic, phenotypic, and clinical characterization of ST11-KL25 and ST11-KL64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital, 2020-2023.
   Antimicrob Agents Chemother. 2026 Feb 19:e0108025. doi: 10.1128/aac.01080.
   PubMed         Abstract available
   
   
3. LEE Y-L, Wang W-Y, Huang Y-T, Ho M-W, et al
   In vitro activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023.
   Antimicrob Agents Chemother. 2026 Feb 18:e0154925. doi: 10.1128/aac.01549.
   PubMed         Abstract available
   
   
4. NISHIHARA Y, Nakano R, Nakano A, Suzuki Y, et al
   Differences in beta-lactamase activity and carbapenem resistance among the Bacillus cereus group.
   Antimicrob Agents Chemother. 2026 Feb 9:e0130225. doi: 10.1128/aac.01302.
   PubMed         Abstract available
   
   
5. ZHENG X, You X, Liu Y, Wu B, et al
   Spatiotemporal dynamics and multiple driving factors of antimicrobial resistance in China during the COVID-19 pandemic (2019-2023): a provincial panel data analysis.
   Antimicrob Agents Chemother. 2026 Feb 9:e0160025. doi: 10.1128/aac.01600.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

6. GREEN AS, Li JZ, Sax PE
   Is Two Drug Therapy with Dolutegravir and Lamivudine an Appropriate Option for People with HIV and Historic Lamivudine Resistance?
   Clin Infect Dis. 2026 Feb 10:ciag061. doi: 10.1093.
   PubMed        
   
   
7. MISHRIKY F, Chan PA
   Antimicrobial resistance concerns should not limit doxycycline post-exposure prophylaxis implementation for bacterial STI prevention.
   Clin Infect Dis. 2026 Feb 9:ciag075. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

8. LAURY JE, Forsberg K, Berkow EL, Jones S, et al
   Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022-2023.
   Emerg Infect Dis. 2026;32:308-310.
   PubMed         Abstract available
   
   
9. LONG GS, Neale M, Braukmann T, Tran V, et al
   Genomic Analysis of Doxycycline Resistance-Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum.
   Emerg Infect Dis. 2026;32:242-245.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

10. WOLFORD H, Khan MA, Paul P, Toth DJA, et al
    Projected impact of a pathogen reduction intervention on carbapenem-resistant Enterobacterales bloodstream infections and deaths in the United States.
    Infect Control Hosp Epidemiol. 2026 Feb 10:1-7. doi: 10.1017/ice.2025.10335.
    PubMed         Abstract available
    
    

    
    Int J Antimicrob Agents

11. BIESNER K, Djukic M, Reichard U, Nau R, et al
    Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared to Mueller-Hinton broth and artificial cerebrospinal fluid.
    Int J Antimicrob Agents. 2026 Feb 9:107730.
    PubMed         Abstract available
    
    
12. WAHID B, Nang SC, Zhao J, Kho ZY, et al
    Phage Resistance Bidirectionally Altered Antibiotic Susceptibility in Klebsiella pneumoniae via galE mutation.
    Int J Antimicrob Agents. 2026 Feb 7:107738.
    PubMed         Abstract available
    
    
13. GENG J, Cheng C, Liu X, Long J, et al
    Global distribution and genomic architectures of plasmid-mediated quinolone resistance genes in Shigella from 1998 to 2025.
    Int J Antimicrob Agents. 2026 Feb 6:107737.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

14. KIM SH, Kim HM, Chung DR, Ko JH, et al
    In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
    J Antimicrob Chemother. 2026;81:dkag031.
    PubMed         Abstract available
    
    
15. ROTUNDO S, Russo A, Morena R, Garofalo E, et al
    Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study.
    J Antimicrob Chemother. 2026;81:dkag056.
    PubMed         Abstract available
    
    
16. CIACCIO L, Donnan PT, Parcell BJ, Marwick CA, et al
    Impact of COVID-19-related healthcare changes on antibiotic resistance in clinical Escherichia coli isolates: interrupted time series analyses in Scotland, UK.
    J Antimicrob Chemother. 2026;81:dkag049.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

17. HENIN N, Silvant A, Gardette M, Balcon C, et al
    Clinical performance of two commercial PCR assays for the detection of macrolide resistance in Mycoplasma pneumoniae.
    J Clin Microbiol. 2026 Feb 13:e0149125. doi: 10.1128/jcm.01491.
    PubMed         Abstract available
    
    
18. WIESMANN N, Enders D, Westendorf A, Koch R, et al
    Correction for Wiesmann et al., "Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study".
    J Clin Microbiol. 2026 Feb 13:e0188425. doi: 10.1128/jcm.01884.
    PubMed        
    
    

    
    J Infect Chemother

19. OGAWA S, Fukushima S, Yamamoto M, Tsuji S, et al
    Comments on "In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan".
    J Infect Chemother. 2026;32:102933.
    PubMed        
    
    

    
    J Infect Dis

20. HALL CW, Waglechner N, Choi E, Aftanas P, et al
    Evaluation of Phenotypic and Genotypic Susceptibility Testing Methods for Newer beta-lactam/beta-lactamase Inhibitor Combinations in Multidrug Resistant Pseudomonas aeruginosa.
    J Infect Dis. 2026;233:e541-e549.
    PubMed         Abstract available
    
    
21. CAMPBELL P
    The Influence of National Antibiotic Consumption on Neisseria gonorrhoeae Antibiotic Resistance in Norway, 2003-2024.
    J Infect Dis. 2026 Feb 11:jiag076. doi: 10.1093.
    PubMed         Abstract available
    
    
22. XU L, Li J, Wu W, Dou L, et al
    Decoding hypervirulence in carbapenem-resistant Klebsiella pneumoniae: genomic and phenotypic profiling reveals capsular polysaccharide as a key driver of pathogenicity.
    J Infect Dis. 2026 Feb 9:jiag075. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

23. HOLT CJD, Wiliams CC, Usher J
    Galleria mellonella as a versatile model for investigating Candida glabrata virulence and antifungal resistance.
    J Med Microbiol. 2026;75:002127.
    PubMed         Abstract available
    
    

    
    J Virol

24. WONG J, Moore T, Lewis D, Lieber CM, et al
    Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus.
    J Virol. 2026;100:e0154125.
    PubMed         Abstract available
    
    

    
    PLoS One

25. ABDESSELAM K, Muchaal PK, Mishra A, Ngendabanka RJ, et al
    AMR surveillance in Canada: Insights from the 2025 Priority Pathogen List.
    PLoS One. 2026;21:e0341133.
    PubMed         Abstract available
    
    
26. MARIN-CARVAJAL S, Quiceno Torres M, Zuleta MC, Torres S, et al
    Whole-genome sequencing, phenotypic characterization, and antifungal susceptibility profiles of three Aspergillus hortae clinical isolates from Colombia.
    PLoS One. 2026;21:e0342479.
    PubMed         Abstract available
    
    

    
    Sex Transm Infect

27. GRANT A, Keegan S, Kulasegaram R
    Role of long-acting injectables in perinatally acquired HIV, with persistent viraemia and non-nucleoside reverse transcriptase inhibitor resistance.
    Sex Transm Infect. 2026;102:107-108.
    PubMed         Abstract available
    
    
28. TSOUMANIS A, Vanbaelen T, Van Dijck C, Kenyon C, et al
    Screening for gonorrhoea and chlamydia: identifying key target populations and intensity-a modelling study of MSM in Belgium.
    Sex Transm Infect. 2026;102:66-73.
    PubMed         Abstract available
    
    

    
    Virology

29. LI M, Guo R, Qi Z, Liu Y, et al
    Antibacterial activity of single Klebsiella phage and phage cocktail against clinical carbapenem-resistant Klebsiella pneumoniae in vitro.
    Virology. 2026;618:110840.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum